These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 1879918)

  • 21. Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion.
    Baron SD; Singh R; Metzger DW
    Infect Immun; 2007 May; 75(5):2152-62. PubMed ID: 17296747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity.
    Richard K; Mann BJ; Qin A; Barry EM; Ernst RK; Vogel SN
    Clin Vaccine Immunol; 2017 Mar; 24(3):. PubMed ID: 28077440
    [No Abstract]   [Full Text] [Related]  

  • 23. Susceptibility of immunodeficient mice to aerosol and systemic infection with virulent strains of Francisella tularensis.
    Chen W; KuoLee R; Shen H; Conlan JW
    Microb Pathog; 2004 Jun; 36(6):311-8. PubMed ID: 15120157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intranasal administration of a two-dose adjuvanted multi-antigen TMV-subunit conjugate vaccine fully protects mice against Francisella tularensis LVS challenge.
    McCormick AA; Shakeel A; Yi C; Kaur H; Mansour AM; Bakshi CS
    PLoS One; 2018; 13(4):e0194614. PubMed ID: 29684046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model.
    Tian D; Uda A; Park ES; Hotta A; Fujita O; Yamada A; Hirayama K; Hotta K; Koyama Y; Azaki M; Morikawa S
    Microbiol Immunol; 2018 Jan; 62(1):24-33. PubMed ID: 29171073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purified lipopolysaccharide from Francisella tularensis live vaccine strain (LVS) induces protective immunity against LVS infection that requires B cells and gamma interferon.
    Dreisbach VC; Cowley S; Elkins KL
    Infect Immun; 2000 Apr; 68(4):1988-96. PubMed ID: 10722593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Virulence comparison in mice of distinct isolates of type A Francisella tularensis.
    Twine SM; Shen H; Kelly JF; Chen W; Sjöstedt A; Conlan JW
    Microb Pathog; 2006 Mar; 40(3):133-8. PubMed ID: 16448801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of an essential Francisella tularensis subsp. tularensis virulence factor.
    Qin A; Scott DW; Thompson JA; Mann BJ
    Infect Immun; 2009 Jan; 77(1):152-61. PubMed ID: 18981253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toll-like receptor 4 (TLR4) does not confer a resistance advantage on mice against low-dose aerosol infection with virulent type A Francisella tularensis.
    Chen W; KuoLee R; Shen H; Bùsa M; Conlan JW
    Microb Pathog; 2004 Oct; 37(4):185-91. PubMed ID: 15458779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific antibodies protect gamma-irradiated mice against Francisella tularensis infection.
    Kubelkova K; Krocova Z; Balonova L; Pejchal J; Stulik J; Macela A
    Microb Pathog; 2012; 53(5-6):259-68. PubMed ID: 22841607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The immune response against Francisella tularensis live vaccine strain in Lps(n) and Lps(d) mice.
    Macela A; Stulik J; Hernychova L; Kroca M; Krocova Z; Kovarova H
    FEMS Immunol Med Microbiol; 1996 Mar; 13(3):235-8. PubMed ID: 8861035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protection of vaccinated mice against pneumonic tularemia is associated with an early memory sentinel-response in the lung.
    Bar-On L; Cohen H; Elia U; Rotem S; Bercovich-Kinori A; Bar-Haim E; Chitlaru T; Cohen O
    Vaccine; 2017 Dec; 35(50):7001-7009. PubMed ID: 29102170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge.
    Jia Q; Bowen R; Lee BY; Dillon BJ; Masleša-Galić S; Horwitz MA
    Vaccine; 2016 Sep; 34(41):4969-4978. PubMed ID: 27577555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular immunology of experimental primary tularemia in mice infected by respiratory or intradermal routes with type A Francisella tularensis.
    Conlan JW; Zhao X; Harris G; Shen H; Bolanowski M; Rietz C; Sjostedt A; Chen W
    Mol Immunol; 2008 May; 45(10):2962-9. PubMed ID: 18321578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nature of protective immunity to Francisella tularensis.
    Tärnvik A
    Rev Infect Dis; 1989; 11(3):440-51. PubMed ID: 2665002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preclinical testing of a vaccine candidate against tularemia.
    Suresh RV; Ma Z; Sunagar R; Bhatty V; Banik S; Catlett SV; Gosselin EJ; Malik M; Bakshi CS
    PLoS One; 2015; 10(4):e0124326. PubMed ID: 25897786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo modulation of the murine immune response to Francisella tularensis LVS by administration of anticytokine antibodies.
    Leiby DA; Fortier AH; Crawford RM; Schreiber RD; Nacy CA
    Infect Immun; 1992 Jan; 60(1):84-9. PubMed ID: 1729199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytokine response in Balb/c mice infected with Francisella tularensis LVS and the Pohang isolate.
    Kim EJ; Park SH; Choi YS; Shim SK; Park MY; Park MS; Hwang KJ
    J Vet Sci; 2008 Sep; 9(3):309-15. PubMed ID: 18716452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IKKβ in myeloid cells controls the host response to lethal and sublethal Francisella tularensis LVS infection.
    Samaniego S; Marcu KB
    PLoS One; 2013; 8(1):e54124. PubMed ID: 23349802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A defined O-antigen polysaccharide mutant of Francisella tularensis live vaccine strain has attenuated virulence while retaining its protective capacity.
    Sebastian S; Dillon ST; Lynch JG; Blalock LT; Balon E; Lee KT; Comstock LE; Conlan JW; Rubin EJ; Tzianabos AO; Kasper DL
    Infect Immun; 2007 May; 75(5):2591-602. PubMed ID: 17296751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.